DOI QR코드

DOI QR Code

Utilization Trends and Concentration Ratio of Korean Medicine: Based on the National Health Insurance Data

  • Lee, Hye-Jae (Department of Pharmacy, College of Pharmacy, Woosuk University) ;
  • Jeong, Hye In (Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Kim, Kyeong Han (Woosuk Institute of Smart Convergence Life Care (WSCLC), Woosuk University)
  • Received : 2021.07.20
  • Accepted : 2021.08.23
  • Published : 2021.09.30

Abstract

Objectives: Although Korean Medicine (KM) subsidized by the National Health Insurance (NHI) has been used for a long time, there has been no active analysis using claims data. Therefore, the purpose of this study was to examine the NHI KM utilization trend using NHI statistics and to measure the level of market concentration by year. Methods: By restructuring the contents of NHI Statistics for Pharmaceuticals for 2010-2019, the claim cases, costs, and annual growth rates of KM were demonstrated by year, sex, age group, region, therapeutic group, and KM treatment. The proportion of highly used k treatments in cost was calculated as the concentration ratio (CR) k and its trend by year was investigated. Results: In 2019, the NHI cost on KM amounted to ₩38.2 billion KRW, increasing by 11.6% per year on average in 2010-2019. Notably, KM was used more frequently among women and patients aged ≥ 65 years, and the mixed formulation accounted for 95% of the total cost of KM. The CR of the simple formulation increased rapidly, whereas that of the mixed formulation remained constant. In 2019, three simple formulation treatments- peony, licorice, and ginseng- accounted for 93.8% of the total cost for KM (CR3 = 93.8%). Conclusion: NHI KM is rapidly increasing. Investigating the CR of KM confirmed that KM prescriptions have been concentrated in small numbers over the past 10 years.

Keywords

Acknowledgement

This research was conducted with the support of the Research Service Project of the Korea Institute of Korean Medicine.

References

  1. National Law Information Center. Pharmaceutical Affairs Act [Internet]. Sejong: Ministry of Government Legislation; 2021 [cited 2021 Feb 19]. Available from: https://www.law.go.kr/.
  2. Health Insurance Review & Assessment Service. Notice No.2020-338 List of Herbal Medicinal Preparations Covered with National Health Insurance and Upper Limit Amount Table [Internet]. Wonju: Health Insurance Review & Assessment Service; 2020 [cited 2021 Feb 19]. Available from: https://www.hira.or.kr/rd/insuadtcrtr/bbsView.do?pgmid=HIRAA030069000400&brdScnBltNo=4&brdBltNo=51741&isPopupYn=Y.
  3. Wonkwang University Industry-Academic Cooperation Group. A Report for the Rational Improvement of the Standard Prescription of Herbal Medicine [Internet]. Wonju: Health Insurance Review & Assessment Service; 2014 [cited 2021 Aug 6]. Available from: https://policy.kiom.re.kr/sub0401/articles/view/tableid/sub0301-board/page/20/id/313.
  4. Lee I, Park SM, Park SC, Kim DH, Cho MK, Han CW, et al. Overview of the interaction between warfarin and Korean herbal medicine. Korean J Orient Int Med. 2012;33(2):160-71.
  5. Kim DH, Lee DE, Noh JW, Ahn YM, Ahn SY, Lee BC. A study of the co-administration of herbal and Western medicines to hospitalized patients with osteoarthritis. J Int Korean Med. 2018;39(2):97-106. https://doi.org/10.22246/jikm.2018.39.2.97
  6. Park HJ, Oh MS, Kim EJ, Lee SG, Park SK, Kim YK. The analysis of main diseases and herbal preparations in herbal health insurance. Korea J Herbol. 2006;21(4):1-10.
  7. Kang SH, Kim JH, Jang SB, Lee MY, Lee JA, Park SJ. Herbal medicine prescription analyses of bronchiectasis patients with claim data during 5 years (2013~2017). J Soc Prev Korean Med. 2019;23(3):1-12.
  8. Kwon YC, Yoo WK, Seo BI. A study on the current status of prescribed drugs in oriental health insurance and their improvement. Korea J Herbol. 2012;27(2):1-16. https://doi.org/10.6116/kjh.2012.27.2.1
  9. Kim KH, Lee EK, Go HY, Chang SW, Ju SW, Jang BH, et al. The awareness and satisfaction of herbal medicine preparations of Korean medicine doctor. J Soc Prev Korean Med. 2017;21(2):15-22. https://doi.org/10.25153/spkom.2017.21.2.002
  10. Health Insurance Review & Assessment Service. National Health Insurance Drug Statistics 2019 [Internet]. Wonju: Health Insurance Review & Assessment Service; 2020 [cited 2021 Feb 19]. Available from: http://www.hira.or.kr/bbsDummy.do?pgmid=HIRAA020045010000&brdScnBltNo=4&brdBltNo=2331&pageIndex=1.
  11. Heo J. Reimbursement price, market structure, and pharmaceutical firm behavior in Korea [dissertation]. [Seoul]: Seoul National University; 2011. 187 p.